call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Europe Veterinary Vaccine Market
Inquire Before Buying Request for Sample

Europe Veterinary Vaccine Market

Home Healthcare And Pharmaceutical Europe Veterinary Vaccine Market

SPECIAL OFFER : 25% Super Discount For All !

Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Administration (Subcutaneous, Intramuscular, Intranasal); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029

  • Published Date: August 2023
  • Report ID: BWC23679
  • Available Format: PDF
  • Page: 200

Report Overview

Increasing pet adoption rates, rising awareness about animal health, growing prevalence of zoonotic diseases, advancements in biotechnology, and government initiatives to control and prevent animal diseases are propelling the growth of the Europe Veterinary Vaccine Market during the forecast period between 2023 and 2029.

Europe Veterinary Vaccine Market – Industry Trends & Forecast Report, 2029

Europe veterinary vaccine market size was estimated at USD 3,208.92 million in 2022. During the forecast period between 2023 and 2029, the size of Europe veterinary vaccine market is projected to grow at a CAGR of 5.71% reaching a value of USD 4,477.33 million by 2029. The Europe veterinary vaccine market is witnessing significant growth. Demand for vaccines is increasing due to rising awareness about animal health and the prevention of diseases. Manufacturers are continuously innovating to develop more effective and safer vaccines. Government initiatives and regulations are supporting the market's expansion, encouraging vaccine research and development. The market is driven by a growing pet population and the need to protect livestock from diseases. Veterinary clinics and animal husbandry facilities are adopting vaccination programs. Overall, the Europe veterinary vaccine market shows a promising outlook, with steady advancements in the field of animal healthcare and disease prevention.

Europe Veterinary Vaccine Market

Europe Veterinary Vaccine Market - Overview

Veterinary vaccines are essential tools in safeguarding the health and well-being of animals. These vaccines are specifically designed to prevent or reduce the incidence of various infectious diseases in animals, ranging from livestock, such as cattle, pigs, and poultry, to domestic pets like dogs and cats. By stimulating the animal's immune system, vaccines create a protective response against harmful pathogens, such as viruses and bacteria, thereby preventing disease transmission. Regular vaccination not only promotes animal welfare but also contributes to public health by reducing zoonotic disease risks. Veterinary vaccines play a pivotal role in maintaining the health of animal populations and supporting sustainable agricultural practices.

Growth Drivers

Advancements in Veterinary Research

Europe's veterinary vaccine market is experiencing significant growth due to ongoing advancements in veterinary research. As new and emerging infectious diseases continue to pose threats to animals, the demand for effective and innovative vaccines has surged. The region's focus on preventive healthcare measures for pets and livestock, along with increased awareness among animal owners, has further fueled the market's expansion. Also, government initiatives promoting vaccination campaigns and the adoption of stringent regulations to ensure animal welfare have contributed to the market's positive trajectory. These factors combined have created a conducive environment for the continuous development and adoption of veterinary vaccines across Europe.

Restraints

Europe's Veterinary Vaccine Market Faces Regulatory Hurdles

In the burgeoning veterinary vaccine market of Europe, regulatory constraints emerge as a critical challenge. The region's diverse regulatory landscape complicates the approval process, causing delays in market access for novel vaccines. Also, stringent safety and efficacy requirements demand extensive and costly clinical trials, impacting market entry for smaller players. The need for compliance with multiple national and EU-wide regulations further intensifies the struggle. Post-Brexit uncertainties in the UK's regulatory framework add another layer of complexity. As demand for advanced animal healthcare solutions rises, stakeholders grapple with navigating the intricate regulatory web to unlock the market's full potential.

Impact of COVID-19 on Europe Veterinary Vaccine Market

The COVID-19 pandemic significantly impacted the Europe veterinary vaccine market, driving accelerated growth. As lockdowns were imposed, people spent more time at home, resulting in increased pet adoption rates and heightened awareness of animal health. Veterinarians reported a surge in demand for vaccines to protect companion animals. With disruptions in food supply chains, farmers sought to safeguard livestock health, leading to a rise in demand for livestock vaccines. The pandemic also prompted governments and private sector investment in vaccine research and development. These factors combined to propel the Europe veterinary vaccine market to new heights amid the crisis.

Europe Veterinary Vaccine Market

Segmental Coverage

Europe Veterinary Vaccine Market – By Product

Based on product, Europe veterinary vaccine market is bifurcated into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines segments. The Attenuated Live Vaccines segment is the largest in the Europe veterinary vaccine market. This segment involves vaccines that contain weakened forms of the disease-causing organisms to stimulate a protective immune response in animals. Attenuated live vaccines are widely used in veterinary medicine due to their ability to provide robust and long-lasting immunity against various diseases, making them a popular choice among veterinarians and livestock owners.

Europe Veterinary Vaccine Market Share

Europe Veterinary Vaccine Market – By Animal Type

By animal type, Europe veterinary vaccine market is split into Livestock and Companion. The livestock segment is further categorized into Poultry, Aqua, Ruminants, and Swine. Also, the companion segment is sub-segmented into Canine and Feline. The livestock segment represents the vaccination needs for various farm animals, contributing significantly to the overall market. The companion segment, on the other hand, includes canine and feline sub-segments, catering to vaccination requirements for domestic pets. However, it is the livestock segment holds a larger share, reflecting the importance of safeguarding and maintaining the health of livestock animals in the European veterinary vaccine market.

Europe Veterinary Vaccine Market – By Route of Administration

By route of administration, Europe veterinary vaccine market is divided into Subcutaneous, Intramuscular, and Intranasal segments. These segments represent different methods of administering vaccines to animals. Subcutaneous vaccines are injected beneath the skin, while Intramuscular vaccines are injected into the muscle tissue. Intranasal vaccines, on the other hand, are administered through the nasal passages. Each segment offers distinct advantages in terms of effectiveness, ease of application, and targeted response. Veterinary professionals and pet owners can choose the most suitable vaccine administration method based on specific animal health needs and preferences.

Europe Veterinary Vaccine Market – By Country

By country, Europe veterinary vaccine market is divided into Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, the Netherlands, and Rest of Europe. Each country represents a distinct market with its own unique dynamics, regulatory environments, and demands for veterinary vaccines. These divisions allow stakeholders in the industry to better understand and target specific regions for product distribution and marketing strategies. The segmentation is crucial for analyzing market trends, competition, and opportunities in the European veterinary vaccine sector.

Competitive Landscape

Major players in the Europe veterinary vaccine market include Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim Gmbh, Elanco, Virbac, Heska, and Dechra Pharmaceuticals Plc. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe

Product/ Service Segmentation

Product, Animal Type, Route of Administration, Country

Key Players

Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim Gmbh, Elanco, Virbac, Heska, Dechra Pharmaceuticals Plc

 

 

By Product

  • Attenuated Live Vaccines

  • Inactivated Vaccines

  • Subunit Vaccines

  • DNA Vaccines

  • Recombinant Vaccines

By Animal Type

  • Livestock

  1. Poultry

  2. Aqua

  3. Ruminants

  4. Swine

  • Companion

  1. Canine

  2. Feline

By Route of Administration

  • Subcutaneous

  • Intramuscular

  • Intranasal

By Country

  • Germany

  • United Kingdom

  • Italy

  • France

  • Spain

  • Belgium

  • Russia

  • The Netherlands

  • Rest of Europe

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Europe Veterinary Vaccine Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing pet ownership
        2. Growing livestock production
      2. Restraints
        1. High research and development costs
      3. Opportunities
        1. Rising prevalence of zoonotic diseases
      4. Challenges
        1. Stringent regulatory requirements
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Europe Veterinary Vaccine Market Overview
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
        1. Attenuated Live Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. DNA Vaccines
        5. Recombinant Vaccines
      2. By Animal Type
        1. Livestock
          1. Poultry
          2. Aqua
          3. Ruminants
          4. Swine
        2. Companion
          1. Canine
          2. Feline
          3. Others
      3. By Route of Administration
        1. Subcutaneous
        2. Intramuscular
        3. Intranasal
      4. By Country
        1. Germany
        2. United Kingdom
        3. Italy
        4. France
        5. Spain
        6. Belgium
        7. Russia
        8. The Netherlands
        9. Rest of Europe
  5. Germany Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  6. United Kingdom Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  7. Italy Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  8. France Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  9. Spain Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  10. Belgium Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  11. Russia Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  12. Netherlands Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  13. Rest of Europe Veterinary Vaccine Market
    1. Market Product & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Animal Type
      3. By Route of Administration
  14. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Europe Veterinary Vaccine Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  15. Impact of Covid-19 on Europe Veterinary Vaccine Market
  16. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Zoetis
    2. Ceva Santé Animale
    3. Merck & Co., Inc.
    4. Vetoquinol S.A.
    5. Boehringer Ingelheim Gmbh
    6. Elanco
    7. Virbac
    8. Heska
    9. Dechra Pharmaceuticals Plc
    10. Other Prominent Players
  17. Key Strategic Recommendations
  18. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

          

List of Figures

 

Figure 1       Europe Veterinary Vaccine Segmentation     

Figure 2       Europe Veterinary Vaccine Market Value Chain Analysis   

Figure 3       Company Market Share Analysis, 2022

Figure 4       Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029  

Figure 5       Europe Veterinary Vaccine Market Share, By Product, By Value, 2019–2029  

Figure 6       Europe Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029         

Figure 7       Europe Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 8       Europe Veterinary Vaccine Market Share, By Country, By Value, 2019–2029 

Figure 9       Germany Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029

Figure 10     Germany Veterinary Vaccine Market Share, By Product, By Value, 2019–2029

Figure 11     Germany Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029         

Figure 12     Germany Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 13     United Kingdom Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029 

Figure 14     United Kingdom Veterinary Vaccine Market Share, By Product, By Value, 2019–2029 

Figure 15     United Kingdom Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029 

Figure 16     United Kingdom Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029

Figure 17     Italy Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029      

Figure 18     Italy Veterinary Vaccine Market Share, By Product, By Value, 2019–2029      

Figure 19     Italy Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029

Figure 20     Italy Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 21     France Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029   

Figure 22     France Veterinary Vaccine Market Share, By Product, By Value, 2019–2029  

Figure 23     France Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029         

Figure 24     France Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 25     Spain Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029    

Figure 26     Spain Veterinary Vaccine Market Share, By Product, By Value, 2019–2029    

Figure 27     Spain Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029         

Figure 28     Spain Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 29     Belgium Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029

Figure 30     Belgium Veterinary Vaccine Market Share, By Product, By Value, 2019–2029

Figure 31     Belgium Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029         

Figure 32     Belgium Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 33     Russia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029   

Figure 34     Russia Veterinary Vaccine Market Share, By Product, By Value, 2019–2029   

Figure 35     Russia Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029         

Figure 36     Russia Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029 

Figure 37     Netherlands Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029         

Figure 38     Netherlands Veterinary Vaccine Market Share, By Product, By Value, 2019–2029         

Figure 39     Netherlands Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029 

Figure 40     Netherlands Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029

Figure 41     Rest of Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029 

Figure 42     Rest of Europe Veterinary Vaccine Market Share, By Product, By Value, 2019–2029 

Figure 43     Rest of Europe Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029 

Figure 44     Rest of Europe Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029

 

List of Tables

 

Table 1        Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029  

Table 2        Europe Veterinary Vaccine Market Size, By Product, By Value, 2019–2029    

Table 3        Europe Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029         

Table 4        Europe Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 5        Europe Veterinary Vaccine Market Size, By Country, By Value, 2019–2029    

Table 6        Germany Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029

Table 7        Germany Veterinary Vaccine Market Size, By Product, By Value, 2019–2029 

Table 8        Germany Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029         

Table 9        Germany Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 10      United Kingdom Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029 

Table 11      United Kingdom Veterinary Vaccine Market Size, By Product, By Value, 2019–2029         

Table 12      United Kingdom Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029 

Table 13      United Kingdom Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029

Table 14      Italy Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029      

Table 15      Italy Veterinary Vaccine Market Size, By Product, By Value, 2019–2029

Table 16      Italy Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029 

Table 17      Italy Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 18      France Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029   

Table 19      France Veterinary Vaccine Market Size, By Product, By Value, 2019–2029     

Table 20      France Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029         

Table 21      France Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 22      Spain Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029    

Table 23      Spain Veterinary Vaccine Market Size, By Product, By Value, 2019–2029       

Table 24      Spain Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029

Table 25      Spain Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 26      Belgium Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029

Table 27      Belgium Veterinary Vaccine Market Size, By Product, By Value, 2019–2029   

Table 28      Belgium Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029         

Table 29      Belgium Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 30      Russia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029   

Table 31      Russia Veterinary Vaccine Market Size, By Product, By Value, 2019–2029     

Table 32      Russia Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029         

Table 33      Russia Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029 

Table 34      Netherlands Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029         

Table 35      Netherlands Veterinary Vaccine Market Size, By Product, By Value, 2019–2029         

Table 36      Netherlands Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029 

Table 37      Netherlands Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029

Table 38      Rest of Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029 

Table 39      Rest of Europe Veterinary Vaccine Market Size, By Product, By Value, 2019–2029         

Table 40      Rest of Europe Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029 

Table 41      Rest of Europe Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029

Table 42      Zoetis Company Overview

Table 43      Zoetis Financial Overview

Table 44      Ceva Santé Animale Company Overview

Table 45      Ceva Santé Animale Financial Overview

Table 46      Merck & Co., Inc. Company Overview

Table 47      Merck & Co., Inc. Financial Overview

Table 48      Vetoquinol S.A. Company Overview

Table 49      Vetoquinol S.A. Financial Overview

Table 50      Boehringer Ingelheim Gmbh Company Overview

Table 51      Boehringer Ingelheim Gmbh Financial Overview

Table 52      Elanco Company Overview

Table 53      Elanco Financial Overview

Table 54      Virbac Company Overview

Table 55      Virbac Financial Overview

Table 56      Heska Company Overview

Table 57      Heska Financial Overview

Table 58      Dechra Pharmaceuticals Plc Company Overview

Table 59      Dechra Pharmaceuticals Plc Financial Overview      

 

 

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The livestock segment accounts for the highest market share in the Europe Veterinary Vaccine Market by animal type.
Ans: The attenuated live vaccines segment accounts for the highest market share in Europe Veterinary Vaccine Market by product.
Ans: Europe Veterinary Vaccine Market size was estimated at USD 3,208.92 million in 2022.
Ans: Major factors driving the growth of Europe Veterinary Vaccine Market include increasing pet adoption rates, rising awareness about animal health, growing prevalence of zoonotic diseases, advancements in biotechnology, and government initiatives to control and prevent animal diseases.
Ans: Key players in Europe Veterinary Vaccine Market include Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim Gmbh, Elanco, Virbac, Heska, and Dechra Pharmaceuticals Plc.